Pacira Biosciences, Inc. (PCRX)
19.30
+0.14
(+0.76%)
USD |
NASDAQ |
Jan 20, 16:00
19.30
0.00 (0.00%)
After-Hours: 20:00
Pacira Biosciences EPS Diluted (Quarterly): 0.1222 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0558 |
| Hologic, Inc. | 0.8298 |
| CorMedix, Inc. | 1.259 |
| Krystal Biotech, Inc. | 2.660 |
| Arcutis Biotherapeutics, Inc. | 0.0558 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.432M |
| Revenue (Quarterly) | 179.52M |
| Total Expenses (Quarterly) | 174.08M |
| Enterprise Value | 1.003B |
| Gross Profit Margin (Quarterly) | 72.93% |
| Profit Margin (Quarterly) | 3.03% |
| Earnings Yield | 2.31% |
| Operating Earnings Yield | 6.70% |
| Normalized Earnings Yield | 3.835 |